EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Use of a long-term continuous glucose monitor for predicting sulfonylurea dose in patients with neonatal diabetes mellitus: a case series

Koji Tagawa, Katsuyuki Matsui, Atsushi Tsukamura, Masami Shibata, Hidemi Tsutsui, Shizuyo Nagai, Yoshihiro Maruo

Clinical Pediatric Endocrinology · 2024 · 33 (3) · 131-138

DOI: 10.1297/cpe.2023-0062 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Pediatric Endocrinology, 2024. Verfasst von Koji Tagawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Shiga University of Medical Science, Shiga, Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neonatal diabetes mellitus (NDM) is a monogenic form of diabetes that presents with uncontrolled hyperglycemia during the first 6 months of life. NDM is a rare disease in which gene variants mainly cause β-cell loss or dysfunction (6q24 duplication, KCNJ11, and ABCC8). Although NDM is primarily treated through insulin therapy, it is highly challenging to manage blood glucose levels using insulin therapy during infancy. In contrast, KCNJ11 and ABCC8 mutant patients received oral sulfonylureas (SU) instead of insulin injections; however, the dose and frequency differ among individuals. Continuous glucose monitoring (CGM) is useful in patients with type 1 diabetes; but reports on patients with NDM are lacking. Herein, we report two cases of NDM with the KCNJ11 variant. We used CGM not only during insulin injection therapy but also after switching to oral SU therapy. The CGM data can also be used to determine the dose and frequency of SU. Furthermore, long-term CGM may be useful for adjusting SU dose and frequency, and maintaining good glycemic control not only during insulin injection but also during oral SU therapy.

Schlagwörter

Stichwörter der Autor:innen

continuous glucose monitoring (CGM)glycemic controlneonatal diabetessulfonylurea

Autor:innen und Institutionen

  • Department of Pediatrics, Shiga University of Medical Science, Shiga, Japan.
  • Department of Pediatrics, Sapporo Tokushukai Hospital, Hokkaido, Japan.
  • Division of Endocrinology, Metabolism & Diabetes, Shiga Medical Center for Children, Shiga, Japan.
  • Department of Pediatrics, Ogaki Municipal Hospital, Gifu, Japan.

Zitieren

APA

Tagawa, K., Matsui, K., Tsukamura, A., Shibata, M., Tsutsui, H., Nagai, S., & Maruo, Y. (2024). Use of a long-term continuous glucose monitor for predicting sulfonylurea dose in patients with neonatal diabetes mellitus: a case series. Clinical Pediatric Endocrinology, 33(3), 131-138. https://doi.org/10.1297/cpe.2023-0062

Vancouver

Tagawa K, Matsui K, Tsukamura A, Shibata M, Tsutsui H, Nagai S, et al. Use of a long-term continuous glucose monitor for predicting sulfonylurea dose in patients with neonatal diabetes mellitus: a case series. Clinical Pediatric Endocrinology. 2024;33(3):131-138. doi:10.1297/cpe.2023-0062

BibTeX
@article{Tagawa2024,
  author = {Tagawa, Koji and Matsui, Katsuyuki and Tsukamura, Atsushi and Shibata, Masami and Tsutsui, Hidemi and Nagai, Shizuyo and Maruo, Yoshihiro},
  title = {Use of a long-term continuous glucose monitor for predicting sulfonylurea dose in patients with neonatal diabetes mellitus: a case series},
  journal = {Clinical Pediatric Endocrinology},
  year = {2024},
  volume = {33},
  number = {3},
  pages = {131--138},
  doi = {10.1297/cpe.2023-0062}
}
Kostenlos starten →